Testing effectiveness (Phase 2)Active Not RecruitingNCT05185947
What this trial is testing
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer
Who this might be right for
Gynecologic CancerGynecologic NeoplasmsPeritoneal Carcinomatosis+7 more
National Cancer Institute (NCI) 19